The Era of Disease-Modifying Therapy for Duchenne Muscular Dystrophy: Outlining Care Pathways for the Evolving Needs of the Patient
October 26, 2020
October 26, 2021
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Postgraduate Institute for Medicine and PlatformQ Health Education, LLC working in collaboration with the National Organization for Rare Disorders and Parent Project Muscular Dystrophy
This activity is supported by educational grants from PTC Therapeutics and Sarepta Therapeutics.
- Physicians — maximum of 1.00 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity is intended for pediatricians, neurologists, neuromuscular specialists, pediatric neurologists, primary care physicians, endocrinologists, gastroenterologists, pediatric cardiologists, physiatrists, pulmonologists, advanced practitioners (NPs and PAs), pharmacists, nurses, and dieticians.
At the conclusion of this activity, participants will be able to:
- Develop an enhanced index of suspicion for DMD in patients who present with signs and symptoms
- Recognize mutations associated with DMD and how they relate to treatment decisions
- Integrate key components of multidisciplinary care for patients with DMD, from initiation of targeted therapy to long-term care
- Assess the therapeutic potential of available and emerging treatment options for the management of DMD
John Brandsema, MD
Neuromuscular Section Head
The Children’s Hospital of Philadelphia
Richard Shell, MD
Professor of Pediatrics
The Ohio State University
Section Chief of Pulmonary Medicine
Nationwide Children’s Hospital
Melissa Gibbons, MS, CGC
University of Colorado School of Medicine
Certified Genetic CounselorBIO
Children’s Hospital Colorado
Rachel Schrader, MS, APRN, CPNP-PC
Senior Vice President, Clinical Care
Parent Project Muscular Dystrophy
Carole Drexel, PhD
Vice President Patient Education and Strategy
PlatformQ Health Education, LLC
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and PlatformQ Health Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
John Brandsema, MD
- Consulting: Audentes, AveXis, Biogen, Genentech, Momenta, NS Pharma, PTC Therapeutics, Sarepta, Scholar Rock, WaVe
- Fees for Non-CME/CE Services: AveXis, Biogen
- Contracted Research: Alexion, AveXis, Biogen, CSL Behring, Pfizer, PTC Therapeutics, Sarepta, WaVe
Richard Shell, MD has no financial relationships to disclose.
Melissa Gibbons, MS, CGC
- Fees for Non-CME/CE : Biogen Services
Rachel Schrader, MS, APRN, CPNP-PC has no financial relationships to disclose.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Carole Drexel, PhD has no financial relationships to disclose.
The PIM planners and managers have nothing to disclose.
The following PlatformQ Health Education, LLC planner, Alissa Stone, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Disclosure of Unapproved/Off Label Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Method of Participation
There are no fees to participate in this activity. To participate in the activity, go to www.NeuroSeriesLive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test.
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Please contact the Postgraduate Institute for Medicine at www.pimed.com.
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting email@example.com with the subject line “Data Request”